课题基金 / 基金详情

CORRECTION OF INHERITED PROTEIN DEFICIENCIES BY GENE THERAPY

CORRECTION OF INHERITED PROTEIN DEFICIENCIES BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
批准号:
3859899
负责人:
E I GINNS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

E I GINNS的其他基金

相关文献

中文摘要
翻译
人正常和异常蛋白质的分离与鉴定 影响神经系统的遗传性疾病允许分离 可用于纠正遗传蛋白质的cDNA和基因组DNA 使用基因治疗的缺陷。特别适合于最初的尝试 用于基因治疗的是那些疾病(如高谢病,最 常见鞘脂沉积症),全身性和神经性 这种障碍的表现是由于 造血细胞,如巨噬细胞。在这些情况下,转移 正常基因对特定组织或骨髓祖细胞的作用 是一种基本的治疗方法。利用溶酶体障碍高雪病 以疾病为模型,我们利用逆转录病毒载体转移和表达 人葡萄糖脑苷酶在小鼠和高雪病患者细胞系中的表达。这个 完全纠正高雪氏成纤维细胞中的葡萄糖脑苷酶活性 为逆转录病毒载体的评价提供了动力 葡萄糖脑苷酶基因导入Gaucher小鼠模型的研究 疾病。逆转录病毒介导的酪氨酸羟基酶转导 对DOPA缺陷态的校正也进行了研究。受体介导 组织内的基因转移也在研究中。最初的目标是 本研究是基因治疗在非神经性疾病中的应用。 表型。利用靶向技术开发转基因动物模型 胚胎干细胞中的同源重组产生小鼠模型 人类疾病的威胁。作为L的仓库的重组操纵的细胞- 多巴释放用于移植到动物的神经系统 模特们。当我们了解遗传性疾病的发病机制时 神经和精神疾病得到改善,并通过逆转录病毒介导 基因在特定组织和细胞中的表达变得更可预测, 我们可以将基因疗法的使用扩展到某些疾病的治疗上 影响神经系统。
英文摘要
The isolation and characterization of normal and abnormal proteins in genetic disorders affecting the nervous system permits the isolation of cDNA and genomic DNA that can be used to correct inherited protein deficiencies using gene therapy. Particularly suited for initial attempts at gene therapy are those disorders (such as Gaucher disease, the most common sphingolipidosis) in which the systemic and neurologic manifestations of the disorder are the consequences of abnormalities of hematopoietic cells, like the macrophage. In these instances that transfer of normal genes to either specific tissue or bone marrow progenitor cells is a rationale therapeutic approach. Using the lysosomal disorder Gaucher disease as a model, we utilized retroviral vectors to transfer and express human glucocerebrosidase in mouse and Gaucher patient cell lines. The complete correction of glucocerebrosidase activity in Gaucher fibroblasts in culture has provided the impetus for evaluation of retroviral mediated gene transfer of the glucocerebrosidase gene into a mouse model of Gaucher disease. Retroviral mediated transfer of tyrosine hydroxylase for the correction of DOPA deficiency states is also studied. Receptor mediated gene transfer into tissues is also being investigated. The initial goal of this research is the application of gene therapy to the non-neuronopathic phenotypes. Transgenic animal models are developed using targeted homologous recombination in embryonic stem cells to generate mouse models of human disease. Recombinantly manipulated cells that act as depots of L- DOPA release are used for transplantation into the nervous system of animal models. When our understanding of the pathogenic mechanisms of inherited neurological and psychiatric diseases improves and as retroviral-mediated expression of genes in specific tissues and cells becomes more predictable, we can extend the use of gene therapy to treatment of selected disorders affecting the nervous system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR GENETICS OF LYSOSOMAL DISORDERS
MOLECULAR GENETIC STUDIES OF THE MUCOPOLYSACCHARIDOSES
GENE REGULATION WITHIN THE NERVOUS SYSTEM
STUDIES OF GAUCHER DISEASE AND OTHER NEUROGENETIC DISORDERS TOWARD GENE THERAPY